Low serum tryptophan predicts higher mortality in cardiovascular disease - PubMed
Low serum tryptophan predicts higher mortality in cardiovascular disease
Christian Murr et al. Eur J Clin Invest. 2015 Mar.
Abstract
Background: The essential amino acid tryptophan is required for protein synthesis and formation of the neurotransmitter serotonin and may exert immunoregulatory functions. An accelerated tryptophan breakdown rate is associated with inflammation and immune activation.
Materials and methods: Serum concentrations of free tryptophan, neopterin and high-sensitivity C-reactive protein (hsCRP) were measured in 1196 patients with coronary artery disease (CAD) derived from the LUdwigshafen RIsk and Cardiovascular Health (LURIC) study.
Results: Tryptophan concentrations did not differ between patients with (mean ± SD: 40.1 ± 9.8 μM) or without (42.3 ± 23.9 μM; not significant, Welch's test) angiographic CAD, but patients with CAD had higher neopterin (9.1 ± 8.2 nM) and hsCRP (9.3 ± 18.5 mg/L) concentrations compared to patients without (neopterin: 7.6 ± 4.7 nM, hsCRP: 5.8 ± 7.6 mg/L; both P < 0.0001). There existed an inverse correlation between serum tryptophan and neopterin (Spearman's rank correlation: rs = -0.273) and hsCRP (rs = -0.163; both P < 0.0001) concentrations. Median observation time was 10.5 years, and 385 patients had died, including 244 patients due to cardiovascular and 132 due to noncardiovascular causes. After adjustments for cardiovascular risk factors and other possible confounders, the hazard ratio (with 95% CI) in the first tryptophan quartile of the study population was 1.51 (1.19-1.90; P = 0.0006) for total mortality, 1.41 (1.05-1.89; P = 0.0224) for cardiovascular and 1.79 (1.20-2.67; P = 0.0042) for noncardiovascular mortalities, respectively, thus indicating a significantly higher risk of death in patients with tryptophan concentrations < 34 μM.
Conclusions: Low serum tryptophan in patients with CAD is associated with immune activation and indicates reduced life expectancy.
Keywords: C-reactive protein; Coronary artery disease; neopterin; tryptophan.
© 2015 Stichting European Society for Clinical Investigation Journal Foundation.
Similar articles
-
Murr C, Pilz S, Grammer TB, Kleber ME, Meinitzer A, Boehm BO, Marz W, Fuchs D. Murr C, et al. Clin Chem Lab Med. 2012 Dec;50(12):2205-12. doi: 10.1515/cclm-2012-0157. Clin Chem Lab Med. 2012. PMID: 23093269
-
Murr C, Grammer TB, Meinitzer A, Kleber ME, März W, Fuchs D. Murr C, et al. J Amino Acids. 2014;2014:783730. doi: 10.1155/2014/783730. Epub 2014 Feb 10. J Amino Acids. 2014. PMID: 24660059 Free PMC article.
-
Murr C, Winklhofer-Roob BM, Schroecksnadel K, Maritschnegg M, Mangge H, Böhm BO, Winkelmann BR, März W, Fuchs D. Murr C, et al. Atherosclerosis. 2009 Feb;202(2):543-9. doi: 10.1016/j.atherosclerosis.2008.04.047. Epub 2008 May 15. Atherosclerosis. 2009. PMID: 18556000
-
Neopterin production, tryptophan degradation, and mental depression--what is the link?
Widner B, Laich A, Sperner-Unterweger B, Ledochowski M, Fuchs D. Widner B, et al. Brain Behav Immun. 2002 Oct;16(5):590-5. doi: 10.1016/s0889-1591(02)00006-5. Brain Behav Immun. 2002. PMID: 12401473 Review.
-
Crucial role of interferon-gamma and stimulated macrophages in cardiovascular disease.
Schroecksnadel K, Frick B, Winkler C, Fuchs D. Schroecksnadel K, et al. Curr Vasc Pharmacol. 2006 Jul;4(3):205-13. doi: 10.2174/157016106777698379. Curr Vasc Pharmacol. 2006. PMID: 16842138 Review.
Cited by
-
Metri NJ, Butt AS, Murali A, Steiner-Lim GZ, Lim CK. Metri NJ, et al. Int J Tryptophan Res. 2023 Nov 29;16:11786469231211184. doi: 10.1177/11786469231211184. eCollection 2023. Int J Tryptophan Res. 2023. PMID: 38034059 Free PMC article.
-
Metabolic Reprogramming, Gut Dysbiosis, and Nutrition Intervention in Canine Heart Disease.
Li Q. Li Q. Front Vet Sci. 2022 Feb 15;9:791754. doi: 10.3389/fvets.2022.791754. eCollection 2022. Front Vet Sci. 2022. PMID: 35242837 Free PMC article. Review.
-
Altered Metabolomic Profile in Patients with Peripheral Artery Disease.
Ismaeel A, Franco ME, Lavado R, Papoutsi E, Casale GP, Fuglestad M, Mietus CJ, Haynatzki GR, Smith RS, Bohannon WT, Sawicki I, Pipinos II, Koutakis P. Ismaeel A, et al. J Clin Med. 2019 Sep 14;8(9):1463. doi: 10.3390/jcm8091463. J Clin Med. 2019. PMID: 31540015 Free PMC article.
-
Kappel BA, De Angelis L, Heiser M, Ballanti M, Stoehr R, Goettsch C, Mavilio M, Artati A, Paoluzi OA, Adamski J, Mingrone G, Staels B, Burcelin R, Monteleone G, Menghini R, Marx N, Federici M. Kappel BA, et al. Mol Metab. 2020 Jun;36:100976. doi: 10.1016/j.molmet.2020.100976. Epub 2020 Mar 13. Mol Metab. 2020. PMID: 32251665 Free PMC article.
-
Calvani R, Picca A, Rodriguez-Mañas L, Tosato M, Coelho-Júnior HJ, Biancolillo A, Laosa O, Gervasoni J, Primiano A, Santucci L, Giampaoli O, Bourdel-Marchasson I, Regueme SC, Sinclair AJ, Urbani A, Landi F, Gambassi G, Marini F, Marzetti E. Calvani R, et al. Metabolites. 2023 Apr 10;13(4):542. doi: 10.3390/metabo13040542. Metabolites. 2023. PMID: 37110200 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous